about
Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsReport on the use of non-clinical studies in the regulatory evaluation of oncology drugsMolecular testing in lung cancer in the era of precision medicineBeyond ALK-RET, ROS1 and other oncogene fusions in lung cancerThe minority report: targeting the rare oncogenes in NSCLCStructural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors.Testing for ROS1 in non-small cell lung cancer: a review with recommendationsMolecular pathways: ROS1 fusion proteins in cancer.Activated RET and ROS: two new driver mutations in lung adenocarcinoma.Novel targets in non-small cell lung cancer: ROS1 and RET fusionsRecent Advances in Targeting ROS1 in Lung Cancer.ROS1 fusions in cancer: a review.Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR.Mouse models for ROS1-fusion-positive lung cancers and their application to the analysis of multikinase inhibitor efficiency.The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis.[Clinical significance of ROS1 rearrangements in non-small cell lung cancer].Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers.Autochthonous murine models for the study of smoker and never-smoker associated lung cancers
P2860
Q26741318-79D75E4C-B701-401F-8E00-7B4C04140B20Q26766039-1483502C-14EB-410D-B5BD-0DB4F531815FQ26824599-91968A69-74A1-439C-A0FB-8280B2D49348Q26851421-816A098A-0017-4306-81D7-D3A4F3EC41A6Q26851636-1815BD4A-1495-444B-86E5-FE5865D85F2AQ27853214-3A7F2C34-D825-497B-93D6-524C6A7691A7Q28070062-163DB866-4B11-4571-970C-BB23BA6AA5C7Q34347504-63F1DDC0-249E-4330-AC51-076DBD9044C1Q35206630-ABC0D7C0-DC77-4BA9-951C-16EA0EE2F4C2Q37038500-AE5D05DC-BA2B-4F01-8D54-6BEA12B34704Q38640765-9F8B7F94-BC31-4F92-8662-EC53DD62345FQ38852070-F622C2D6-033D-4DE4-A00A-C930F05EC005Q38955578-BEF1D228-3348-4037-A58C-191161F08734Q39930964-1D202751-09E4-44B5-95A5-9F3F26C02900Q49887888-9A57BB97-8CC3-4EA4-9DDB-08AA6AAB6D59Q53031630-5EB792FF-6425-4D1D-A1D7-109F0A21A78CQ54389938-5260CBA3-5B90-47D7-8D09-C127391B9574Q54399363-BEB47A09-70DA-404A-BAC3-805C05F93B9DQ58804389-14C38AFD-DB08-4C90-9C4D-0524CDBEA4EC
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mouse model for ROS1-rearranged lung cancer
@ast
Mouse model for ROS1-rearranged lung cancer
@en
Mouse model for ROS1-rearranged lung cancer
@nl
type
label
Mouse model for ROS1-rearranged lung cancer
@ast
Mouse model for ROS1-rearranged lung cancer
@en
Mouse model for ROS1-rearranged lung cancer
@nl
prefLabel
Mouse model for ROS1-rearranged lung cancer
@ast
Mouse model for ROS1-rearranged lung cancer
@en
Mouse model for ROS1-rearranged lung cancer
@nl
P2093
P2860
P1433
P1476
Mouse model for ROS1-rearranged lung cancer
@en
P2093
Akihiko Yoshida
Fumie Hosoda
Hiromi Nakamura
Hiroyuki Takahashi
Hisao Asamura
Hitoshi Tsuda
Koji Tsuta
Michihiro Mutoh
Natsuko Hama
Takashi Kohno
P2860
P304
P356
10.1371/JOURNAL.PONE.0056010
P407
P577
2013-02-13T00:00:00Z